Yayın:
Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study

Araştırma Projeleri

Organizasyon Birimleri

Dergi Sayısı

Özet

Açıklama

Anahtar kelimeler

Bevacizumab, Medicine, Internal medicine, Irinotecan, Oxaliplatin, Colorectal cancer, Oncology, Capecitabine, KRAS, Chemotherapy, Cetuximab, Progression-free survival, Cancer

Alıntı

Koleksiyonlar

Endorsement

Review

Supplemented By

Referenced By